Endologix
ENDOLOGIX INC /DE/ (Form: 3, Received: 11/01/2017 16:08:41)
FORM 3
        
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response...
0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Onopchenko John

2. Date of Event Requiring Statement (MM/DD/YYYY)
10/30/2017 

3. Issuer Name and Ticker or Trading Symbol

ENDOLOGIX INC /DE/ [ELGX]

(Last)        (First)        (Middle)

2 MUSICK

4. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                            _____ 10% Owner
___ X ___ Officer (give title below)          _____ Other (specify below)
Chief Operating Officer /

(Street)

IRVINE, CA 92618       

(City)              (State)              (Zip)
5. If Amendment, Date Original Filed (MM/DD/YYYY)

 

6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person


Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)
2. Amount of Securities Beneficially Owned
(Instr. 4)
3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)
4. Nature of Indirect Beneficial Ownership
(Instr. 5)

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 4)
2. Date Exercisable and Expiration Date
(MM/DD/YYYY)
3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)
4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)
6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares

Explanation of Responses:
No securities are beneficially owned.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Onopchenko John
2 MUSICK
IRVINE, CA 92618


Chief Operating Officer

Signatures
John Onopchenko by Timothy N. Brady Attorney-in-Fact for Reporting Person 11/1/2017
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
LIMITED POWER OF ATTORNEY FOR
SECTION 16 REPORTING OBLIGATIONS

    Know all by these presents, that the undersigned's hereby makes, constitutes
    and appoints Timothy N. Brady, or Vaseem Mahboob, or Jeremy B. Hayden, or
        Noman Ghulamali or Gilbert Hernandez  as the undersigned's true and lawful
    attorney-in-fact, with full power and authority as hereinafter described on
    behalf of and in the name, place and stead of the undersigned to:
(1)    prepare, execute, acknowledge, deliver and file Forms 3, 4, and 5
    (including any amendments thereto) with respect to the securities
    of Endologix, Inc., a Delaware corporation (the "Company"), with
    the United States Securities and Exchange Commission, any national
    securities exchanges and the Company, as considered necessary or
    advisable under Section 16(a) of the Securities Exchange Act of 1934
    and the rules and regulations promulgated thereunder, as amended from
    time to time (the "Exchange Act");
(2)    seek or obtain, as the undersigned's representative and on the
    undersigned's behalf, information on transactions in the Company's
    securities from any third party, including brokers, employee benefit
    plan administrators and trustees, and the undersigned hereby authorizes
    any such person to release any such information to the undersigned and
    approves and ratifies any such release of information; and
(3)    perform any and all other acts which in the discretion of such
    attorney-in-fact are necessary or desirable for and on behalf of the
    undersigned in connection with the foregoing.
    The undersigned acknowledges that:
(1)    this Power of Attorney authorizes, but does not require, such
    attorney-in-fact to act in their discretion on information provided
    to such attorney-in-fact without independent verification of
    such information;
(2)    any documents prepared and/or executed by such attorney-in-fact
    on behalf of the undersigned pursuant to this Power of Attorney
    will be in such form and will contain such information and disclosure
    as such attorney-in-fact, in his or her discretion, deems necessary or
    desirable;
(3)    neither the Company nor such attorney-in-fact assumes (i) any liability
    for the undersigned's responsibility to comply with the requirement of
    the Exchange Act, (ii) any liability of the undersigned for any failure
    to comply with such requirements, or (iii) any obligation or liability
    of the undersigned for profit disgorgement under Section 16(b) of the
    Exchange Act; and
(4)    this Power of Attorney does not relieve the undersigned from responsibility
    for compliance with the undersigned's obligations under the Exchange Act,
    including without limitation the reporting requirements under Section 16
    of the Exchange Act.
    The undersigned hereby gives and grants the foregoing attorney-in-fact full
    power and authority to do and perform all and every act and thing whatsoever
    requisite, necessary or appropriate to be done in and about the foregoing
    matters as fully to all intents and purposes as the undersigned might or
    could do if present, hereby ratifying all that such attorney-in-fact of,
    for an on behalf of the undersigned, shall lawfully do or cause to be done
    by virtue of this Limited Power of Attorney.
    This Power of Attorney shall remain in full force and effect until revoked
    by the undersigned in a signed writing delivered to such attorney-in-fact.
    IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to
    be executed as of this 26th day of October, 2017.

                                                    /s/ John Onopchenko
                            Signature

                                                     John Onopchenko
                            Print Name


STATE OF CALIFORNIA    )
    )    ss.
COUNTY OF SAN DIEGO    )

On 26th day of October, 2017 before me, Michelle Violet Basil, Notary Public, personally
appeared John Onopchenko, who proved to me on the basis of satisfactory evidence to be the
person(s) whose names(s) is/are subscribed to the within instrument and
acknowledged to me that he/she/they executed the same in his/her/their
authorized capacity(ies), and that by his/her/their signature(s) on the
instrument the person(s), or the entity upon behalf of which the person(s)
acted, executed the instrument.
I certify under PENALTY OF PERJURY under the laws of the State of California
that the foregoing paragraph is true and correct.

WITNESS my hand and official seal
/s/ Michelle Violet Basil
SIGNATURE OF NOTARY PUBLIC
March 9, 2018 Commission Expires